Dr Raquel Almodóvar González

• Comprehensive management of inflammatory rheumatic diseases, including rheumatoid arthritis, psoriatic arthritis, axial and peripheral spondyloarthritis and reactive arthritis, with a focus on diagnosis, control of inflammation and personalised follow-up.
• Screening and early diagnosis of psoriatic arthritis or spondyloarthritis in patients with psoriasis, hidradenitis suppurativa, uveitis or inflammatory bowel disease.
• Comprehensive assessment of systemic autoimmune diseases, including lupus, Sjögren’s disease, systemic sclerosis, vasculitis, inflammatory myopathies and antiphospholipid syndrome/obstetric autoimmunity, integrating both joint and systemic manifestations.
• Assessment of primary or secondary Raynaud’s phenomenon.
• Holistic assessment of bone health and fracture risk in peri- and postmenopausal women and in men.
• Assessment of osteoarthritis with a focus on treatment and preservation of function.
• Diagnostic and therapeutic procedures performed during consultation, including arthrocentesis, injections, Schirmer testing, musculoskeletal ultrasound and preparation of structured clinical reports.

Professional Career

• Specialist Physician in Rheumatology at Hospital Universitario Fundación Alcorcón, Madrid, 2003–present.
• Specialist Physician in Rheumatology at Hospital Universitario Doce de Octubre, Madrid, 2002–2003.
• Co-Coordinator of GRESSER, Grupo Español de Estudio de Espondiloartritis of the Sociedad Española de Reumatología, 2023–present.
• Co-Coordinator of multidisciplinary Rheumatology and Gastroenterology meetings for the management of spondyloarthritis and inflammatory bowel disease at Hospital Universitario Fundación Alcorcón, since 2021.
• Co-Coordinator of the multidisciplinary Rheumatology and Dermatology clinic for the management of systemic autoimmune diseases at Hospital Universitario Fundación Alcorcón, since 2025.
• Co-Coordinator of the multidisciplinary team for the management of comorbidities in psoriatic disease at Hospital Universitario Fundación Alcorcón, since 2017.
• Member of the Board of Directors of the Sociedad Española de Reumatología, since May 2026.
• Full member of ASAS, Assessment of SpondyloArthritis international Society, since 2016.
• Vice-President of the Sociedad Española de Reumatología and Head of the SER Committee for Training, Undergraduate Education and Communication, 2018–2022.
• Deputy Secretary of the Sociedad Española de Reumatología and Head of the SER Symposia and Congresses Committee, 2024–2026.
• Full member of the Sociedad Española de Reumatología (SER).
• Member of the Sociedad de Reumatología de la Comunidad de Madrid (SORCOM).

Academic Training

• Degree in Medicine and Surgery from Universidad Complutense de Madrid, 1997.
• Specialist in Rheumatology via the Spanish MIR system at Hospital Universitario Doce de Octubre, Madrid, 1998–2002.
• PhD from Universidad Rey Juan Carlos with the thesis “Nuevas herramientas para mejorar el manejo de pacientes con espondiloartritis”, awarded Cum Laude, 2023.
• Lecturer on the Spondyloarthritis Course of the Sociedad Española de Reumatología in 2022 and on the Master’s Degree in Spondyloarthritis at Universidad Europea de Madrid from 2010 to 2018.
• Panel member for the consensus document on the use of biological and non-biological therapies in psoriatic arthritis.
• Panel member for the SER recommendations on the use of magnetic resonance imaging in the assessment and follow-up of patients with axial spondyloarthritis.
• Co-Coordinator and lecturer on the national training project on magnetic resonance imaging in axial spondyloarthritis for rheumatologists and radiologists, developed by GRESSER and SERME, 2013–present.
• Coordinator and lecturer of the SORCOM Residents’ Workshop on the assessment of patients with rheumatoid arthritis, spondyloarthritis, psoriatic arthritis and systemic autoimmune diseases, 2009–present.
• Co-Coordinator of the Reumafit campaign of the Sociedad Española de Reumatología, aimed at promoting physical activity and exercise among people with rheumatic diseases, 2020–present.
• Coordinator and lecturer of the SORCOM Rheumatology Nursing Workshop on the assessment of patients with spondyloarthritis and psoriatic arthritis in 2008, 2013 and 2016.
• Co-Coordinator of the development of the Ejes 3.0 tool for individualised exercise prescription in people with spondyloarthritis.
• Co-Coordinator of the development of a tool for the assessment of patients with axial spondyloarthritis and psoriatic arthritis in routine clinical practice: ONLY TOOLS project, 2018.
• Co-Coordinator of the development of SCAISS, the Spanish tool for semi-automatic quantification of sacroiliac inflammation on magnetic resonance imaging in spondyloarthritis, and its validation in the Spanish early spondyloarthritis cohort ESPERANZA, 2019–2022.
• Principal investigator or collaborating investigator in various clinical trials and observational studies at Hospital Universitario Fundación Alcorcón, Madrid.

Affiliations

• Coordinator of GRESSER, Grupo Español de Estudio de Espondiloartritis of the Sociedad Española de Reumatología, 2023–present.
• Member of the Board of Directors of the Sociedad Española de Reumatología, May 2026–present.
• Full member of ASAS, Assessment of SpondyloArthritis international Society, 2016–present.
• Vice-President of the Sociedad Española de Reumatología and Head of the SER Committee for Training, Undergraduate Education and Communication, 2018–2022.
• Deputy Secretary of the Sociedad Española de Reumatología and Head of the SER Symposia and Congresses Committee, 2024–2026.
• Full member of the Sociedad Española de Reumatología (SER).
• Member of the Sociedad de Reumatología de la Comunidad de Madrid (SORCOM).

Awards and Distinctions

• First runner-up in the 3rd edition of the Ibero-American “José Román” Award for Research in Spondyloarthritis, June 2012.
• Panel member for ESPOGUIA 2010 and 2015, the national clinical practice guideline for spondyloarthritis.
• Author of numerous national and international scientific publications in the field of inflammatory rheumatic diseases, particularly psoriatic arthritis and spondyloarthritis.